LYMPHOPROLIFERATIVE DISORDERS
Clinical trials for LYMPHOPROLIFERATIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDERS trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stem cell transplant aims to cure rare immune disorders
⭐️ CURE ⭐️ Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can cure people with certain immune system diseases (primary immunodeficiencies). Participants, aged 4 to 69, receive donor stem cells to rebuild a healthy immune system. The goal is to see if the transplant wor…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ CURE ⭐️
Last updated May 01, 2026 15:39 UTC
-
Gene therapy makes its own CAR-T cells to battle bone marrow cancer
Disease control Recruiting nowThis early-stage study tests a new gene therapy called KLN-1010 for people with multiple myeloma that has come back or not responded to treatment. Instead of taking cells out of the body to make them fight cancer, this therapy delivers a gene directly into the body to create canc…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Could a drug already approved for some cancers help people with rare tumors?
Disease control Recruiting nowThis study tests a drug called atezolizumab in people with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). The drug is already approved for certain cancers, and researchers want to see if it works for other cancer types with these ge…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Could a Donor's stem cells fix a broken immune system?
Disease control Recruiting nowThis study is testing whether a blood or bone marrow transplant from a healthy donor can help people aged 4 to 75 with serious immune system disorders. Participants receive chemotherapy before the transplant and must stay near the clinic for months after. The goal is to control t…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Blood cancer biobank aims to unlock personalized treatment clues
Knowledge-focused Recruiting nowThis study collects bone marrow, blood, and tissue samples from over 1,000 people with various blood cancers, including leukemia and myeloma. Researchers will use advanced lab techniques to identify biomarkers and test how cancer cells respond to different drugs. The goal is to b…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated May 01, 2026 15:39 UTC
-
Scientists hunt for new drug targets in blood cancers
Knowledge-focused Recruiting nowThis study looks at cells from people with blood cancers (like leukemia or lymphoma) to understand which drugs might work best. Researchers will test many compounds on these cells in the lab and compare the results with the patients' genetic information. The goal is to find new t…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated May 01, 2026 15:38 UTC